is semaglutide on the shortage list Novo Nordisk's officially concludes in US, spelling major threat for weight loss drug compounders The FDA Removes Semaglutide from

People with higher starting BMI Individuals with BMI above 40 often see faster absolute weight loss in the early phases, simply because a higher body weight means a larger caloric expenditure even at rest, and the same percentage reduction in food intake creates a larger absolute caloric deficit

Orforglipron received FDA approval under the brand name Foundayo

Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study

For many users, stabilizing at a sub-maximum dose provides an excellent balance of efficacy and tolerability

"In certain cases, I may prescribe phentermine when rapid appetite reduction is needed in the short term," she notes